openPR Logo
Press release

PREMIER Biosoft and PamGene International B.V. form an alliance

02-20-2007 07:16 PM CET | IT, New Media & Software

Press release from: PREMIER Biosoft International

Palo Alto, California—February 15th 2007. PREMIER Biosoft International, a leading bioinformatics company, and PamGene International B.V., owner of patented technologies for second-generation microarray products, have come together to develop a software tool to design custom oligos for use in MLPA® based assays.

Multiplex Ligation-dependent Probe Amplification (MLPA®) is a method for assessing tens to hundreds of gene copy number changes, single-nucleotide polymorphisms (SNPs), insertions and deletions and methylation markers in genomic DNA in a single reaction tube. PamGene’s microarray platform detects and quantifies all these MLPA® amplified products with a single array using its flow-through PamChip® microarrays and PamStation® systems.

The alliance will help MLPA® users design custom oligos for use with PamGene's microarrays. Currently, such a tool is not available to the users. "I see great synergies between the two companies. I look forward to working with PamGene to develop such an innovative product", commented Kay Brown, V.P. Business Development and Marketing of PREMIER Biosoft. Rinie van Beuningen, V.P. Business Development, PamGene International added, “With this software tool we are enabling researchers to quickly develop new multiplex genomic assays for use in research and diagnostics”.

About PREMIER Biosoft International:
Founded in 1994, the company is a group of computer scientists and molecular biologists dedicated to producing cutting-edge intuitive software for the molecular biologist. The goal of the company is to study the most recent innovations in molecular biology and translate them into software products that aid biologists. Additional information about PREMIER Biosoft International is available at http://www.PremierBiosoft.com.

About PamGene International
PamGene is a European biotechnology company that owns patented technologies for second-generation microarray products including an innovative transcription profiling system. Its array-based MLPA application, based on Jan Schouten’s discovery in 2002 and using reagents provided by MRC-Holland, accelerates a number of genomic assays. PamGene’s technology and products are for use in pharma-biotech R&D and production, academic research, non-pharma life sciences and health management testing applications. More information about PamGene International can be found at http://www.pamgene.com/

Contact:
Arun Apte
PREMIER Biosoft International
650-856-2703
http://www.PremierBiosoft.com

PREMIER Biosoft International
3786, Corina Way, Palo Alto
California, USA
Phone: 650-856-2703
Fax: 650-618-1773
Email: support@premierbiosoft.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PREMIER Biosoft and PamGene International B.V. form an alliance here

News-ID: 16021 • Views:

More Releases for PamGene

Global Egg Allergy Market: Know Major Reasons for Rise in Recent Period by Top C …
Market Definition: Egg Allergy Market The report provides market overview, Market Segment Upstream and Downstream and Cost Analysis. It analysis the industry by market size, type, top players, demand, Market Price Trends, Factors of Price Change, Manufacturers Gross Margin Analysis. This report furthermore portrays bargains channel, wholesalers, dealers, shippers and statistical surveying Findings and Conclusion, addendum and data source. Information and data mentioned in this report is collected from primary
Global DNA and Gene Chip (Microarrays) Market Top Companies Players, Drivers, Hi …
Market Definition: DNA and Gene Chip (Microarrays) Market DNA and Gene Chip (Microarrays) Market research report offers CAGR value fluctuations during the forecast period of 2018-2025 for the market. It is a fully informative and proficient report that focuses on primary and secondary market drivers, market share, leading segments and geographical analysis. A proficient team works meticulously with their potential capabilities to generate this finest market research report. The market report
Global DNA and Gene Chip (Microarrays) Market Top Companies Players, Drivers, Hi …
Market Definition: DNA and Gene Chip (Microarrays) Market DNA and Gene Chip (Microarrays) Market research report offers CAGR value fluctuations during the forecast period of 2018-2025 for the market. It is a fully informative and proficient report that focuses on primary and secondary market drivers, market share, leading segments and geographical analysis. A proficient team works meticulously with their potential capabilities to generate this finest market research report. The market report
Global DNA and Gene Chip (Microarrays) Market business development strategies ti …
DNA and Gene Chip (Microarrays) market research report offers valuable insights and helps client’s gain higher market share into multiple sections impacting the growth of the market globally. For a better understanding of the market, our market experts provide a comprehensive analysis of the factors defining the the growth of the DNA and Gene Chip (Microarrays) market and encompasses a wide range of factors that will prove crucial to our
Global DNA and Gene Chip (Microarrays) Market Size, Share, Growth, Trends, Type, …
The Global DNA and Gene Chip (Microarrays) Market accounted to USD 1.7 billion in 2016 growing at a CAGR of 13.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Major market drivers and restraints: • Huge Amount of DNA/ Gene Chip Initiatives • Need For Initial Cancer Detection & Cancer
Recent Research Report on “The Global DNA And Gene Chip Market 2018” CAGR of …
The Global DNA And Gene Chip (Microarrays) Market accounted to USD 1.7 billion in 2016 growing at a CAGR of 13.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Market Definition: Global DNA and Gene Chip (Microarrays) Market Microarray technology is used to analyze the gene expression